Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Rev. cuba. endocrinol ; 30(3): e176, sept.-dic. 2019. graf
Artículo en Español | LILACS, CUMED | ID: biblio-1126444

RESUMEN

RESUMEN Los trastornos del desarrollo sexual son estados congénitos en los cuales el desarrollo del sexo cromosómico, gonadal o anatómico es atípico. Por tratarse de un caso sumamente raro consideramos de interés su presentación. Se presenta adolescente masculino de 15 años, con antecedentes de genitales atípicos al nacer, desarrollo de baja talla y estigmas turnerianos, pubertad espontánea y normal. Los estudios genéticos determinaron como sexo cromosómico un mosaico 45,X/46,XY/47XYY, y sexo molecular varón. Se inscribió socialmente como varón, se le realizó cirugía de reconstrucción genital y utilizó tratamiento con hormona de crecimiento biosintética que mantiene actualmente. La evolución clínica ha sido favorable con adecuada integración social. Ante la presencia de genitales atípicos al nacer se necesita de un manejo multidisciplinario. El diagnóstico etiológico de los trastornos de la diferenciación sexual requiere de una alta pericia médica. Un tratamiento integral en estos pacientes les garantiza una buena calidad de vida(AU)


ABSTRACT Sexual development´s disorders are congenital states in which the development of the chromosomal, anatomic or gonadal sex is atypical. Since this is a very rare case, we consider it as of interests for presentation. It is presented a teenager, 15-years-old male, with a history of atypical genitalia at birth, development of short height and Turner's stigmas, and spontaneous and normal puberty. The genetic studies identified as chromosomal sex a mosaic 45,X/46,XY/47XYY and male as molecular sex. He was socially registered as a male, he had a genital reconstruction surgery and he was under treatment with biosynthetic growth hormone that he currently maintains. The clinical evolution has been favourable with adequate social integration. In the presence of atypical genitalia at birth, it is needed a multidisciplinary management. The etiological diagnosis of disorders of sexual differentiation requires a high level of medical expertise. A comprehensive treatment in these patients guarantees them a good quality of life(AU)


Asunto(s)
Humanos , Masculino , Adolescente , Calidad de Vida , Trastornos del Desarrollo Sexual/etiología , Cirugía de Reasignación de Sexo/métodos , Mosaicismo , Diferenciación Sexual , Evolución Clínica
2.
J Nutr Sci Vitaminol (Tokyo) ; 57(5): 333-9, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22293210

RESUMEN

The purpose of this study was to clarify the effects of nutrients on the gonadal development of male rats kept under constant darkness as a model of disturbed daily rhythm. In the present study we examined fat-soluble vitamins and their interactions in this test population. Four fat-soluble vitamins (vitamin A (V.A), vitamin D (V.D), vitamin E (V.E) and vitamin K (V.K)) were selected as experimental factors, and the dietary content of these vitamins was normal (AIN-93G) or three times the normal content. Lighting conditions (constant darkness or normal lighting) were also added as a factor. Four-week-old rats (Fischer 344 strain) were kept under constant darkness or normal lighting (12-h light/dark cycle) for 4 wk. The lighting condition and V.E, and the interactions between the lighting condition and V.E and between V.A and V.D were observed to affect the testes and epididymides weights. There was an influence of the lighting condition only on the seminal vesicles and prostate weights and the serum testosterone concentration. Among the constant darkness groups (D-groups), the highest value for testes weight was observed under the normal-V.A, normal-V.D and high-V.E diet. The interaction between lighting condition and V.E showed the testes weight increased slightly in response to changing to a high-V.E diet from a normal-V.E diet under normal lighting (N-group) but was greatly increased in response to this change in the D-group. It became clear that the amount of dietary V.E necessary for the gonadal development of rats increases when rats are kept under constant darkness.


Asunto(s)
Trastornos Cronobiológicos/fisiopatología , Trastornos del Desarrollo Sexual/prevención & control , Genitales Masculinos/patología , Vitamina A/uso terapéutico , Vitamina D/uso terapéutico , Vitamina E/uso terapéutico , Animales , Suplementos Dietéticos , Trastornos del Desarrollo Sexual/etiología , Trastornos del Desarrollo Sexual/metabolismo , Trastornos del Desarrollo Sexual/patología , Ingestión de Energía , Epidídimo/patología , Masculino , Tamaño de los Órganos , Fotoperiodo , Próstata/patología , Ratas , Ratas Endogámicas F344 , Vesículas Seminales/patología , Testículo/crecimiento & desarrollo , Testosterona/sangre , Vitamina K/uso terapéutico
3.
J Pediatr Endocrinol Metab ; 18(4): 403-11, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15844475

RESUMEN

We report on two German sisters with deficiency in the 17alpha-hydroxylase/17,20-lyase enzyme corresponding to typical hormone profile. A paternal nonsense mutation R388X in exon 7 and a maternal missense mutation P428L in exon 8 of the CYP17 gene have been identified in both girls. Residual in vitro 17alpha-hydroxylase activity for the conversion of [3H]-Preg to [3H]-17OH-Preg has been detected in transfected 293-cells expressing P428L mutant enzyme; however, no 17,20-lyase activity was observed converting [3H]-17OH-Preg into [3H]-DHEA. The 46,XX-sister spontaneously entered puberty. The 46,XY-sister with a predicted adult height of 203 cm was treated with a high dose of conjugated estrogens and resulted with a final height of 186.9 cm. The present data suggest that compound heterozygous 46,XX females bearing a P428L allele may develop spontaneous onset of puberty. Furthermore, in 46,XY females with tall stature, treatment with conjugated estrogens may lead to a significant reduction of their predicted adult height.


Asunto(s)
Hiperplasia Suprarrenal Congénita/complicaciones , Hiperplasia Suprarrenal Congénita/genética , Estatura , Trastornos del Desarrollo Sexual/terapia , Trastornos del Crecimiento/tratamiento farmacológico , Mutación , Esteroide 17-alfa-Hidroxilasa/genética , Adolescente , Adulto , Arginina , Codón sin Sentido , Trastornos del Desarrollo Sexual/complicaciones , Trastornos del Desarrollo Sexual/etiología , Estrógenos/uso terapéutico , Estrógenos Conjugados (USP)/uso terapéutico , Femenino , Trastornos del Crecimiento/complicaciones , Trastornos del Crecimiento/etiología , Heterocigoto , Humanos , Leucina , Mutación Missense , Orquiectomía , Prolina , Pubertad
4.
Cancer ; 59(4): 801-6, 1987 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-3802038

RESUMEN

Thirteen children with medulloblastoma, were studied after 2 to 62 months off radiotherapy and chemotherapy with methotrexate and BCNU. Ages at time of study ranged from 2.3 to 15.7 years. Eleven patients, followed for a mean of 22 months, showed a significant decrease of height score, whereas nine patients had deficient growth hormone (GH) response to provocative tests. Clinical pubertal progression was normal in all patients, and three of five girls with advanced pubertal development had menarche. No evidences of gonadotropin disturbances were found in five patients whereas seven had raised basal follicle-stimulating hormone (FSH) level or FSH response to luteinizing hormone-releasing hormone (LH-RH). Abnormalities in thyrotrophin (TSH) secretion were found in 9 of 13 patients. This study shows that poor growth and GH deficiency were frequent in our patients. The high frequency of thyroid disturbances observed point out the need of evaluating thyroid function for adequate replacement therapy. Perhaps modification of adjuvant chemotherapy in the future can diminish drug-induced gonadal damage.


Asunto(s)
Neoplasias Encefálicas/terapia , Enfermedades del Sistema Endocrino/etiología , Meduloblastoma/terapia , Adolescente , Antineoplásicos/efectos adversos , Niño , Preescolar , Terapia Combinada , Trastornos del Desarrollo Sexual/etiología , Femenino , Gónadas/fisiología , Trastornos del Crecimiento/etiología , Hormona del Crecimiento/análisis , Humanos , Sistema Hipotálamo-Hipofisario/fisiología , Masculino , Radioterapia/efectos adversos , Enfermedades de la Tiroides/etiología , Pruebas de Función de la Tiroides
5.
S Afr Med J ; 60(5): 195-8, 1981 Aug 01.
Artículo en Africano | MEDLINE | ID: mdl-7256463

RESUMEN

New evidence has become available regarding certain aspects of the aetiology and pathogenesis of true hermaphroditism. It is evident that the presence of a Y-chromosome in the karyotype of the true hermaphrodite predisposes to the formation of a testis on the one side and an ovary or an ovotestis on the other side. The presence of 46,XX-chromosome complement, however, more commonly results in an ovotestis on the one side and an ovary on the other side. The formation of an ovotestis is possibly due to a difference in the presence of H-Y-antigen in the cells of the ovarian and the testicular portion. The development of the Müllerian and Wolffian ducts is much more interdependent than has previously been known. No cases have been described where two ducts, both of Wolffian and Müllerian origin, were found next to an ovotestis. In humans, fetal androgen does not change hypothalamic activity to a monophasic pattern or produce male sexual behaviour, according to the evidence found in the true hermaphrodites investigated by us.


Asunto(s)
Trastornos del Desarrollo Sexual/etiología , Aberraciones Cromosómicas Sexuales/fisiopatología , Femenino , Humanos , Hipotálamo/metabolismo , Lactante , Cariotipificación , Masculino , Conductos Paramesonéfricos/fisiología , Ovario/crecimiento & desarrollo , Ovario/patología , Testículo/crecimiento & desarrollo , Testículo/patología , Conductos Mesonéfricos/fisiología , Cromosoma X/fisiología , Cromosoma Y/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA